Skip to main content
Clinical Trials/NCT02253056
NCT02253056CompletedNot Applicable

Montag Ist Fasten-Tag (German) - MIFT [Monday is Fasting Day]

Charite University, Berlin, Germany2 sites in 1 country36 target enrollmentStarted: September 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
36
Locations
2
Primary Endpoint
Insulin-like growth factor 1 and brain-derived neurotrophic factor

Study Overview

Brief Summary

The aim of this pilot study is to evaluate the effects of one regular fasting day per week over a total period of 8 weeks compared to a normal-eating habits among healthy volunteers.

Detailed Description

Participants in the intervention group receive an initial group training for fasting. Then all participants will observe one fixed fasting day per week (monday) over a total period of eight weeks.

Participants in the control group receive an initial group training for healthy diet according to current German guidelines (DGE). Moreover, they will receive the same offer as in the intervention group at the end of the 8-week study period. Until then the control group participants follow a regular healthy diet.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age 18 -65 yrs
  • written informed consent

Exclusion Criteria

  • severe chronic comorbidity
  • eating disorders
  • pregnancy
  • planed pregnancy
  • simultaneous participation in other trials

Outcomes

Primary Outcomes

Insulin-like growth factor 1 and brain-derived neurotrophic factor

Time Frame: Baseline and after 8 weeks

Measurement of changes after 8 weeks

Secondary Outcomes

  • Visual analogue scales and Likert-scales(Baseline, 8 weeks, 6 month)
  • Profile of mood states questionnaire: POMS(Baseline, 8 weeks, 6 month)
  • Anxiety and depression questionnaire: HADS(Baseline, 8 weeks, 6 month)
  • Flourishing questionnaire(Baseline, 8 weeks, 6 month)
  • Quality of life questionnaire: WHO-5(Baseline, 8 weeks, 6 month)
  • Systolic and diastolic bloodpressure(Baseline, 8 weeks)
  • Body Impedance Analysis (BIA)(Baseline, 8 weeks)
  • Body weight and abdominal circumference(Baseline, 8 weeks)
  • Blood: total cholesterol, LDL, HDL, Triglycerides; Insulin, GOT,GPT, GGT, AP; HbA1c; PTT, INR(Baseline and 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andreas Michalsen

Prof. Dr. med. Andreas Michalsen

Charite University, Berlin, Germany

Study Sites (2)

Loading locations...

Similar Trials